Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v24-EN | Version v8-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2023-11-01 | 2023-04-13 |
| Drug Identification Number | 00514500 | 00514500 |
| Brand name | LONITEN 10MG | LONITEN 10MG |
| Common or Proper name | LONITEN | LONITEN |
| Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
| Ingredients | MINOXIDIL | MINOXIDIL |
| Strength(s) | 10MG | 10MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 1x100 PBTL | 1x100 PBTL |
| ATC code | C02DC | C02DC |
| ATC description | ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON | ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-09-27 | 2023-05-31 |
| Actual start date | ||
| Estimated end date | 2023-11-16 | Unknown |
| Actual end date | 2023-10-31 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Available inventory is on preventive allocation | |
| Health Canada comments |